Filing Details

Accession Number:
0001179110-21-002869
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-04 16:17:29
Reporting Period:
2021-03-02
Accepted Time:
2021-03-04 16:17:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1650664 Editas Medicine Inc. EDIT () MA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226288 C James Mullen C/O Editas Medicine, Inc.,
11 Hurley St.
Cambridge MA 02141
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-02 25,000 $46.27 35,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2021-03-02 196,637 $0.00 196,637 $45.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
196,637 2031-03-01 No 4 A Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $46.27 to $46.44. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This option was granted on March 2, 2021 and is scheduled to vest as to one-third of the shares underlying the option when the closing price of the Issuer's common stock, as reported on the Nasdaq Global Select Market, has for 15 consecutive trading days in the five year period following the grant date equaled or exceeded $80.00, $100.00 and $120.00 per share, respectively.